Ritter P S, Bauer M, Pilhatsch M
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland,
Nervenarzt. 2014 Nov;85(11):1432-5. doi: 10.1007/s00115-014-4132-5.
The treatment of depressive episodes is characterized by a delay in response of antidepressant medications and high rates of therapeutic failure. In recent years several open and five controlled trials have demonstrated the antidepressant efficacy of ketamine for major depression. In addition a recent study established the utility of nasal ketamine which may render the necessity of intravenous administration obsolete. The current state of evidence is reviewed and discussed.
抑郁发作的治疗特点是抗抑郁药物起效延迟且治疗失败率高。近年来,多项开放性试验和五项对照试验已证明氯胺酮对重度抑郁症具有抗抑郁疗效。此外,最近的一项研究证实了鼻内使用氯胺酮的效用,这可能使静脉注射变得不再必要。本文对现有证据的状况进行了综述和讨论。